New peptide inhibitor of dipeptidyl peptidase IV, EMDB-1 extends the half-life of GLP-2 and attenuates colitis in mice after topical administration

Maciej Sałaga , Anna Mokrowiecka , M. Zielińska , Ewa Małecka-Panas , Radzisław Kordek , Elżbieta Kamysz , Jakub Fichna

Abstract

n/a
Author Maciej Sałaga
Maciej Sałaga,,
-
, Anna Mokrowiecka
Anna Mokrowiecka,,
-
, M. Zielińska
M. Zielińska,,
-
, Ewa Małecka-Panas
Ewa Małecka-Panas,,
-
, Radzisław Kordek
Radzisław Kordek,,
-
, Elżbieta Kamysz PChMB
Elżbieta Kamysz,,
- Laboratory of Chemistry of Biological Macromolecules
, Jakub Fichna
Jakub Fichna,,
-
Journal seriesJournal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565
Issue year2017
Vol363
No1
Pages92-103
Publication size in sheets2.2
Keywords in Englishcolitis, inflammatory bowel disease (IBD), protease inhibitors
DOIDOI:10.1124/jpet.117.242586
URL http://jpet.aspetjournals.org/content/early/2017/07/19/jpet.117.242586.full-text.pdf
Languageen angielski
Score (nominal)35
ScoreMinisterial score = 35.0, 20-12-2017, ArticleFromJournal
Ministerial score (2013-2016) = 35.0, 20-12-2017, ArticleFromJournal
Publication indicators WoS Impact Factor: 2016 = 3.867 (2) - 2016=3.784 (5)
Citation count*0
Cite
Share Share

Get link to the record
msginfo.png


* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Back